| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/14/2008 | WO2007137149A3 Use of cathepsin k antagonists in bone production |
| 02/14/2008 | WO2007136760A3 Method of growth of mesenchymal cells under non-adherent conditions for clinical applications |
| 02/14/2008 | WO2007135685A3 Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof |
| 02/14/2008 | WO2007127927A3 Differentiation of human embryonic stem cells |
| 02/14/2008 | WO2007103379A3 Method for endothelial cell extraction from adipose tissues |
| 02/14/2008 | WO2007067782A3 Compositions and methods for inducing the activation of immature monocytic dendritic cells |
| 02/14/2008 | WO2007058267A8 Novel protein and gene encoding the protein |
| 02/14/2008 | WO2007031875A3 Modified antigen binding molecules with altered cell signaling activity |
| 02/14/2008 | US20080040821 Transgenic ungulates capable of human antibody production |
| 02/14/2008 | US20080039943 Set For Treating The Degeneracy Of An Intervertebral Disc |
| 02/14/2008 | US20080039940 Biological Tissue Sheet, Method Of Forming The Same And Transplantation Method By Using The Sheet |
| 02/14/2008 | US20080039939 Method of Constructing Artificial Joint |
| 02/14/2008 | US20080039680 Process for Enriching a Population of Sperm Cells |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039417 Protein Tyrosine Phosphate Mutations in Cancers |
| 02/14/2008 | US20080039413 Novel compositions and methods in cancer |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039409 Method of Suppressing Cancer |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039392 CRAC channel and modulator screening methods |
| 02/14/2008 | US20080039386 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 02/14/2008 | US20080039385 Neublastin Variants |
| 02/14/2008 | US20080039363 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 02/14/2008 | US20080039341 Unstructured recombinant polymers and uses thereof |
| 02/14/2008 | US20080039335 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 02/14/2008 | US20080038823 Method of Separating Pancreatic Islet |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038821 contains an aminated polyrotaxane in which at least some of hydroxy groups in the cyclodextrin structure are each substituted with a substituent having an amino group; |
| 02/14/2008 | US20080038820 Induction of pluripotent stem cells into mesodermal lineages |
| 02/14/2008 | US20080038819 Micro Rna Inhibiting the Expression of Wt1 Gene and Utilization of the Same |
| 02/14/2008 | US20080038818 Method for Sterilization of Biological Preparations |
| 02/14/2008 | US20080038817 Method of harvesting tissue intraoperatively |
| 02/14/2008 | US20080038814 Nanotube mat with an array of conduits for biological cells |
| 02/14/2008 | US20080038806 Magnetic Manipulation of Biological Samples |
| 02/14/2008 | US20080038799 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038798 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
| 02/14/2008 | US20080038797 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038796 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038795 Polyunsaturated fatty acids (PUFA); from Shewanella japonica and Shewanella olleyana; beta -ketoacyl-ACP acyltransferase activity; recombinant microbial, plant cells |
| 02/14/2008 | US20080038794 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038792 Polyunsaturated fatty acids (PUFA); FabA-like beta-hydroxy acyl-ACP dehydrase activity and enoyl ACP-reductase activity; recombinant plant/microbial cells |
| 02/14/2008 | US20080038791 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038790 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038777 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 02/14/2008 | US20080038770 neuroblastoma tumor-initiating cells derived from a bone marrow aspirate or a tumor sample taken from the body of an individual having neuroblastoma disease; used for screening a sample to identify the stage of neuroblastoma present; drug screening anticarcinogenic agent for treating neuroblastoma |
| 02/14/2008 | US20080038755 Cellspot applications |
| 02/14/2008 | US20080038741 T1R taste receptors and genes encoding same |
| 02/14/2008 | US20080038735 Tus DNA binding domains |
| 02/14/2008 | US20080038728 Quadruple Transformed Cell Line Useful for the Identification of Transport Inhibitors |
| 02/14/2008 | US20080038721 Sequence Capable Of Accelerating Gene Expression At Moderately Low Temperature |
| 02/14/2008 | US20080038717 Enrichment method for variant proteins with altered binding properties |
| 02/14/2008 | US20080038716 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 02/14/2008 | US20080038710 Seeding the scaffold layers with cells, biologically active molecules, or combinations thereof; stacking the at least two scaffold layers; bonding using a gas in the absence of a solvent or an adhesive into the three dimensional scaffold |
| 02/14/2008 | US20080038378 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038372 Artificial Physiological Salt Solution and Manufacturing Method for Same |
| 02/14/2008 | US20080038365 TRPC6 involved in glomerulonephritis |
| 02/14/2008 | US20080038352 Electroprocessed Collagen and Tissue Engineering |
| 02/14/2008 | US20080038296 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 02/14/2008 | US20080038293 compositions provide immune response up to and including protective immunity against porcine reproductive and respiratory syndrome (PRRS) as well as reduce the severity of PRRS virus (PRRSV) and/or incidence of PRRSV |
| 02/14/2008 | US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression |
| 02/14/2008 | US20080038281 Model membrane systems |
| 02/14/2008 | US20080038280 A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines |
| 02/14/2008 | US20080038278 GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase |
| 02/14/2008 | US20080038274 Inhibition of secretion from non-neuronal cells |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038272 binds highly specifically and/or selectively to human receptors of the Frizzled family; hybridoma cell that produces the antibody |
| 02/14/2008 | US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038260 specifically bind to monocyte-derived dendritic cells (MDDC); immunostimulants; downmodulating transplant rejection; cancer |
| 02/14/2008 | US20080038257 Hepatocyte growth factor (hgf) binding proteins |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038245 Methods of modulating angiogenesis |
| 02/14/2008 | US20080038238 Human Stem Cell Materials and Methods |
| 02/14/2008 | US20080038236 Biocompatible scaffolds and adipose-derived stem cells |
| 02/14/2008 | US20080038235 Methods for regulating T cell subsets by modulating transcription factor activity |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038233 Treatment of Spinal Conditions |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/14/2008 | US20080038231 Processing procedure for peripheral blood stem cells |
| 02/14/2008 | US20080038230 Method Of Cell Isolation |
| 02/14/2008 | US20080038212 Herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038202 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 02/14/2008 | US20080038200 Model for neurodegenerative diseases involving amyloid accumulation |
| 02/14/2008 | US20080038199 Methods Related to the Treatment of Neurodegenerative and Inflammatory Conditions |
| 02/14/2008 | US20080038155 Tool and Method for Manipulating a Sample of Developmental Cells in a Process of Cryopreservation |
| 02/14/2008 | CA2660035A1 Method of production of transgenic avian using embryonic stem cells |
| 02/14/2008 | CA2660014A1 Tumor suppression using placental stem cells |
| 02/14/2008 | CA2659631A1 Antibodies to erbb2 |
| 02/14/2008 | CA2659535A1 Genetically modified plants which synthesize a starch having increased swelling power |
| 02/14/2008 | CA2659437A1 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 02/14/2008 | CA2659418A1 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887080A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors |
| 02/13/2008 | EP1887079A1 Genetically modified plants synthesizing starch with increased swelling power |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1885867A2 Novel methods |
| 02/13/2008 | EP1885846A2 Epigenetic and genetic treatment method and system |